It was also shown that shRNA-PKM2 induced apoptosis in vitro and in vivo human lung cancer xenografts treated with docetaxel, which suggested that PKM2 could, to some extent, reverse chemotherapy resistance to cancer therapy [45, 46]. This evidence concerns the gene PKM and lung carcinoma.